Literature DB >> 6195067

Quantification of granulocyte elastase inhibitors in human mixed saliva and in pure parotid secretion.

M Ohlsson, M Rosengren, H Tegner, K Ohlsson.   

Abstract

The predominant inhibitors of granulocyte elastase in plasma (alpha 1-proteinase inhibitor and alpha 2-macroglobulin) together with antileukoproteinase were quantified in parotid secretion and mixed saliva. Antileukoproteinase was the only inhibitor found in parotid saliva and was present in a concentration about 30 times the serum level, suggesting a local production. In mixed saliva, antileukoproteinase accounted for more than 70% of the molar concentration of the granulocyte elastase inhibitors studied. alpha 1-Proteinase inhibitor was measurable in about 1/3 of the specimens of mixed saliva. In parotid secretion, antileukoproteinase was present only as a free, active inhibitor. In mixed saliva about 15% of antileukoproteinase was in complex with granulocyte elastase, while the remaining amount of 85% was inhibitorily active. This suggests that antileukoproteinase has a biological function in a local defence mechanism directed towards the effects of granulocyte elastase in the oral cavity and salivary glands.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6195067     DOI: 10.1515/bchm2.1983.364.2.1323

Source DB:  PubMed          Journal:  Hoppe Seylers Z Physiol Chem        ISSN: 0018-4888


  9 in total

1.  A locus on human chromosome 20 contains several genes expressing protease inhibitor domains with homology to whey acidic protein.

Authors:  Adam Clauss; Hans Lilja; Ake Lundwall
Journal:  Biochem J       Date:  2002-11-15       Impact factor: 3.857

Review 2.  Current developments in salivary diagnostics.

Authors:  Craig S Miller; Joseph D Foley; Alison L Bailey; Charles L Campell; Roger L Humphries; Nicolaos Christodoulides; Pierre N Floriano; Glennon Simmons; Bryon Bhagwandin; James W Jacobson; Spencer W Redding; Jeffrey L Ebersole; John T McDevitt
Journal:  Biomark Med       Date:  2010-02       Impact factor: 2.851

3.  Human bronchial leucocyte proteinase inhibitor. Rapid isolation and kinetic analysis with human leucocyte proteinases.

Authors:  C E Smith; D A Johnson
Journal:  Biochem J       Date:  1985-01-15       Impact factor: 3.857

4.  Oxidized mucus proteinase inhibitor: a fairly potent neutrophil elastase inhibitor.

Authors:  C Boudier; J G Bieth
Journal:  Biochem J       Date:  1994-10-01       Impact factor: 3.857

5.  Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase.

Authors:  R C Thompson; K Ohlsson
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

6.  The 2.5 A X-ray crystal structure of the acid-stable proteinase inhibitor from human mucous secretions analysed in its complex with bovine alpha-chymotrypsin.

Authors:  M G Grütter; G Fendrich; R Huber; W Bode
Journal:  EMBO J       Date:  1988-02       Impact factor: 11.598

7.  Production of secretory leucocyte protease inhibitor (SLPI) in human pancreatic beta-cells.

Authors:  M Nyström; M Bergenfeldt; I Ljungcrantz; A Lindeheim; K Ohlsson
Journal:  Mediators Inflamm       Date:  1999       Impact factor: 4.711

8.  Secretory leukocyte protease inhibitor in punch biopsies from human colonic mucosa.

Authors:  M Nyström; U P Westin; C Linder; K Ohlsson
Journal:  Mediators Inflamm       Date:  2001-10       Impact factor: 4.711

9.  Structure basis 1/2SLPI and porcine pancreas trypsin interaction.

Authors:  Kei Fukushima; Takashi Kamimura; Midori Takimoto-Kamimura
Journal:  J Synchrotron Radiat       Date:  2013-09-29       Impact factor: 2.616

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.